Aurobindo Pharma Q4 net spurts to Rs 501 cr

Our Bureau Hyderabad | Updated on November 25, 2017

Aurobindo Pharma Ltd’s consolidated net profit increased manifold at Rs 501 crore in the fourth quarter ended March 31, 2014 compared to Rs 108 crore in the year-ago period driven by growth in formulations sale.

The total revenue of the Hyderabad-based company grew by 48.4 per cent at Rs 2,329 crore (Rs 1,570 cr).

For the full-year, profit increased to Rs 1,173 crore (Rs 294 cr). Total revenue grew to Rs 8,100 crore (Rs 5,855 crore).

Published on May 30, 2014

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor